Flosatidil

CAS No. 113593-34-3

Flosatidil( —— )

Catalog No. M36172 CAS No. 113593-34-3

Flosatidil is a small molecule voltage-gated calcium channel complex (VDCCs) blocker for the treatment of neurological disorders and cardiovascular diseases, and can be used in the study of angina pectoris.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 126 In Stock
10MG 192 In Stock
25MG 314 In Stock
50MG 448 In Stock
100MG 640 In Stock
200MG 866 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Flosatidil
  • Note
    Research use only, not for human use.
  • Brief Description
    Flosatidil is a small molecule voltage-gated calcium channel complex (VDCCs) blocker for the treatment of neurological disorders and cardiovascular diseases, and can be used in the study of angina pectoris.
  • Description
    Flosatidil is a small molecule voltage-gated calcium channel complex (VDCCs) blocker for the treatment of neurological disorders and cardiovascular diseases, and can be used in the study of angina pectoris.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Calcium Channel
  • Recptor
    Calcium Channel
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    113593-34-3
  • Formula Weight
    525.63
  • Molecular Formula
    C26H34F3N3O3S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    N(CC1=CC(C(F)(F)F)=CC=C1)(C(CN(C(OCC(C)C)=O)CCN(C)C)=O)C2=C(SC)C=CC=C2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Synta-66

    A potent, selective CRAC channel Orai1 blocker with IC50 of 3 uM.

  • Hypophyllanthin

    Hypophyllanthin and phyllanthin have antitumour effects against Ehrlich Ascites Carcinoma in mice.

  • Atagabalin

    Atagabalin (PD 0200390) is a novel ligand of the voltage-dependent calcium channel (VDCC) α2δ subunit (1 and 2) for treatment for insomnia.